Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis - PubMed (original) (raw)
Comparative Study
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
A M Cantin et al. Am Rev Respir Dis. 1989 Feb.
Abstract
Glutathione (L-gamma-glutamyl-L-cysteinyl-glycine, GSH), a sulfhydryl-containing tripeptide produced by most mammalian cells, is an efficient scavenger of toxic oxidants, including hydrogen peroxide, an oxidant that plays a major role in the oxidant burden placed on the epithelial surface of the lower respiratory tract in chronic inflammatory states. GSH is present in the epithelial lining fluid of the normal lower respiratory tract, where it is thought to play a major role in providing antioxidant protection to the epithelial cells. In this regard, we hypothesized that the lower respiratory tract of patients with IPF may be chronically depleted of this antioxidant, thus leading to an increased susceptibility of lung epithelial cells to oxidant injury. To evaluate this concept, the concentration of glutathione was determined in the epithelial lining fluid of the lower respiratory tract of 15 patients with IPF and compared to that of 19 normal subjects. Strikingly, whereas ELF glutathione concentrations were high in normal subjects (429 +/- 34 microM), a fourfold decrease was found in patients with IPF (97 +/- 18 microM, p less than 0.001). In the context of the known oxidant burden present in the lower respiratory tract of patients with IPF, these observations of a "GSH deficiency" in IPF ELF suggest that there is a marked oxidant-antioxidant imbalance at the alveolar surface of these persons, thus increasing the susceptibility to the severe epithelial cell damage characteristic of this disease.
Similar articles
- Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
Cantin AM, North SL, Fells GA, Hubbard RC, Crystal RG. Cantin AM, et al. J Clin Invest. 1987 Jun;79(6):1665-73. doi: 10.1172/JCI113005. J Clin Invest. 1987. PMID: 3034979 Free PMC article. - Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis.
Borok Z, Buhl R, Grimes GJ, Bokser AD, Hubbard RC, Holroyd KJ, Roum JH, Czerski DB, Cantin AM, Crystal RG. Borok Z, et al. Lancet. 1991 Jul 27;338(8761):215-6. doi: 10.1016/0140-6736(91)90350-x. Lancet. 1991. PMID: 1676780 - Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.
Meyer A, Buhl R, Kampf S, Magnussen H. Meyer A, et al. Am J Respir Crit Care Med. 1995 Sep;152(3):1055-60. doi: 10.1164/ajrccm.152.3.7663783. Am J Respir Crit Care Med. 1995. PMID: 7663783 - [Therapy of lung diseases with anti-oxidants].
Buhl R, Vogelmeier C. Buhl R, et al. Pneumologie. 1994 Feb;48(2):50-6. Pneumologie. 1994. PMID: 8183872 Review. German. - Oxidants, antioxidants and the pathogenesis of emphysema.
Cantin A, Crystal RG. Cantin A, et al. Eur J Respir Dis Suppl. 1985;139:7-17. Eur J Respir Dis Suppl. 1985. PMID: 2995106 Review.
Cited by
- Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease.
Schamberger AC, Schiller HB, Fernandez IE, Sterclova M, Heinzelmann K, Hennen E, Hatz R, Behr J, Vašáková M, Mann M, Eickelberg O, Staab-Weijnitz CA. Schamberger AC, et al. Sci Rep. 2016 Jul 20;6:29952. doi: 10.1038/srep29952. Sci Rep. 2016. PMID: 27435875 Free PMC article. - Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense.
Joyce-Brady M, Hiratake J. Joyce-Brady M, et al. Curr Enzym Inhib. 2011 Jul;7(2):71-78. doi: 10.2174/157340811796575308. Curr Enzym Inhib. 2011. PMID: 22485086 Free PMC article. - Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.
Liu RM. Liu RM. Antioxid Redox Signal. 2008 Feb;10(2):303-19. doi: 10.1089/ars.2007.1903. Antioxid Redox Signal. 2008. PMID: 17979497 Free PMC article. Review. - GSPE Protects against Bleomycin-Induced Pulmonary Fibrosis in Mice via Ameliorating Epithelial Apoptosis through Inhibition of Oxidative Stress.
Sul OJ, Kim JH, Lee T, Seo KW, Cha HJ, Kwon B, Ahn JJ, Cho YS, Oh YM, Jegal Y, Ra SW. Sul OJ, et al. Oxid Med Cell Longev. 2022 Mar 20;2022:8200189. doi: 10.1155/2022/8200189. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35355866 Free PMC article. - Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?
Veith C, Schneider MA, Maas L, van der Vliet A, van Schooten FJ, Kreuter M, Meister M, Boots AW, Kahn N. Veith C, et al. Antioxidants (Basel). 2023 Feb 10;12(2):443. doi: 10.3390/antiox12020443. Antioxidants (Basel). 2023. PMID: 36830000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical